Effects of oral hormone replacement therapy on mean platelet volume in postmenopausal women
| dc.authorid | Kaygusuz, Ikbal/0000-0002-5635-505X; | |
| dc.contributor.author | Kaygusuz, Ikbal | |
| dc.contributor.author | Simavli, Serap Aynur | |
| dc.contributor.author | Eser, Ayla | |
| dc.contributor.author | Inegol Gumus, Ilknur | |
| dc.contributor.author | Yuksel, Selcen | |
| dc.contributor.author | Iltemir Duvan, Zehra Candan | |
| dc.contributor.author | Kafali, Hasan | |
| dc.date.accessioned | 2025-10-24T18:09:52Z | |
| dc.date.available | 2025-10-24T18:09:52Z | |
| dc.date.issued | 2014 | |
| dc.department | Malatya Turgut Özal Üniversitesi | |
| dc.description.abstract | Background/aim: To examine the effects of hormone replacement therapy (HRT) on mean platelet volume (MPV), lipid profile, and C-reactive protein (CRP) levels in postmenopausal women who have a high risk and incidence of cardiovascular disease. Materials and methods: This study was performed retrospectively. Twenty-seven healthy postmenopausal women received 1 mg estradiol and 2 mg drospirenone orally for 6 months. Twenty-eight healthy postmenopausal women not taking any HRT were admitted to the study as the control population. Results: Time effect (independent from group effect) was statistically significant for the MPV variable (P = 0.025), but there was no significant change in MPV levels and other cardiovascular disease risk markers in women receiving HRT compared to women in the control group. Conclusion: Younger postmenopausal women taking HRT and women who initiated hormone therapy close to menopause are not at increased risk of cardiovascular disease. | |
| dc.identifier.doi | 10.3906/sag-1311-88 | |
| dc.identifier.endpage | 984 | |
| dc.identifier.issn | 1300-0144 | |
| dc.identifier.issn | 1303-6165 | |
| dc.identifier.issue | 6 | |
| dc.identifier.pmid | 25552150 | |
| dc.identifier.scopus | 2-s2.0-84908059063 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 980 | |
| dc.identifier.trdizinid | 213209 | |
| dc.identifier.uri | https://doi.org/10.3906/sag-1311-88 | |
| dc.identifier.uri | https://search.trdizin.gov.tr/tr/yayin/detay/213209 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12899/3871 | |
| dc.identifier.volume | 44 | |
| dc.identifier.wos | WOS:000344155900011 | |
| dc.identifier.wosquality | Q4 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | TR-Dizin | |
| dc.language.iso | en | |
| dc.publisher | Tubitak Scientific & Technological Research Council Turkey | |
| dc.relation.ispartof | Turkish Journal Of Medical Sciences | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_20251023 | |
| dc.subject | Mean platelet volume; menopause; cardiovascular risk; hormone replacement therapy; lipid profile | |
| dc.title | Effects of oral hormone replacement therapy on mean platelet volume in postmenopausal women | |
| dc.type | Article |












